Table 1: Demographic characteristics of the patients at baseline.

Characteristic

Patients (No = 97)

Mean Age (range), y

60 (31-85)

Sexe No (%)

Male

Female

 

72 (74.2)

25 (25.8)

BMI Kg/m2 (Mean + sd)

31.4 + 6.2

SAPS II (mean + sd)

41.5 + 13

SOFA (median)

6

Coexisting disorders No (%)

Arterial hypertension

Diabetes mellitus

Dyslipidemia

Coronary artery disease

Ischemic stroke

Chronic kidney disease

Chronic liver disease

HIV

Cancer

COPD

Asthma

Obstructive sleep apnea

Smoking

Others

 

45 (46.4)

28 (28.9)

22 (22.7)

16 (16.5)

5 (5.2)

8 (8.2)

0

3 (3.1)

5 (5.2)

7 (7.2)

8 (8.2)

18 (18.6)

3 (3.1)

10 (10.4)

Medications No (%)

ARB

CEI

β blockers

Calcic inhibitors

Thiazides

Statins

Antidiabetics

Glucocorticoids

Inhaled steroids

Immune suppressors

NSAI drugs

 

21 (21.6)

14 (14.4)

23 (23.7)

18 (18.6)

16 (16.5)

21 (21.6)

20 (20.6)

5 (5.2)

5 (5.2)

5 (5.2)

2 (2.1)

Mean duration of symptoms before admission (days + sd)

10 + 5

Admission location No (%)

Home

Hospital transfers

 

49 (50.5)

48 (49.5)

Extubated No. (%)

Transferred to other ICU unit No. (%)

Died in our unit No./ total No. (%)

4 (4.1)

60 (61.9)

18 (18.6)

y: Years; BMI: Body Mass Index; SAPS: Simplified Acute Physiology Score; SOFA: Sepsis-related Organ Failure Assessment; HIV: Human immunodeficiency virus; COPD: Chronic Obstruciv Pulmonary Disease; ARB: Angiotensin II Receptor Blocker; CEI: Conversion Enzyme Inhibitor; NSAI: Non-Steroidien Anti-Inflammatory; ICU: Intensive Care Unit.